NCT00668265View on ClinicalTrials.gov

Anxiety in Recovering Opiate Dependence

PHASE4TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Generalized Anxiety DisorderComorbid Opiate Dependence in RemissionStatus Post Methadone-Maintenance Treatment
Interventions
DRUG

Quetiapine

Dosage is 50 - 300 mg, once daily, at bedtime.

Trial Locations (1)

10002

Su Casa Methadone-to-Abstinence Rehabilitation, New York

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Beth Israel Medical Center

OTHER